XML 20 R35.htm IDEA: XBRL DOCUMENT v2.3.0.15
Stock-Based Compensation Stock-Based Compensation (Details) (USD $)
3 Months Ended9 Months Ended
Sep. 30, 2011
years
Sep. 30, 2010
Sep. 30, 2011
years
Sep. 30, 2010
Dec. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]     
Directors' Fees in Stock-Based Compensation$ (415,000)$ (167,000)$ (930,000)$ (499,000) 
Total Stock-Based Compensation2,353,0001,612,0007,363,0004,812,000 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]     
Stock Options, Outstanding, Beginning Balance391,542 391,542 442,880
Stock Options, Exercised  12,561  
Stock Options, Forfeited  26,754  
Stock Options, Expired  12,023  
Stock Options, Outstanding, Ending Balance391,542 391,542 442,880
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]     
Stock Options, Vested and Expected to Vest391,542 391,542  
Stock Options, Exercisable391,542 391,542  
Stock Options, Outstanding, Weighted Average Exercise Price, Beginning Balance  $ 51.85  
Stock Options, Exercised, Weighted Average Exercise Price$ 35.61 $ 35.61  
Stock Options, Forfeited, Weighted Average Exercise Price$ 51.43 $ 51.43  
Stock Options, Expired, Weighted Average Exercise Price  $ 60.18  
Stock Options, Outstanding, Weighted Average Exercise Price, Ending Balance$ 52.14 $ 52.14  
Stock Options, Vested and Expected to Vest, Weighted Average Exercise Price$ 52.14 $ 52.14  
Stock Options, Exercisable, Weighted Average Exercise Price$ 52.14 $ 52.14  
Stock Options, Outstanding, Weighted Average Remaining Contractual Term in Years, Beginning Balance  3.5  
Stock Options, Outstanding, Weighted Average Remaining Contractual Term in Years, Ending Balance3.2 3.2  
Stock Options, Vested and Expected to Vest, Weighted Average Remaining Contractual Term in Years  3.2  
Stock Options, Exercisable, Weighted Average Remaining Contractual Term in Years  3.2  
Stock Options, Outstanding, Aggregate Intrinsic Value, Beginning Balance  (4,255,000)  
Stock Options, Outstanding, Aggregate Intrinsic Value, Ending Balance(6,583,000) (6,583,000)  
Stock Options, Vested and Expected to Vest, Aggregate Intrinsic Value(6,583,000) (6,583,000)  
Stock Options, Exercisable, Aggregate Intrinsic Value(6,583,000) (6,583,000)  
Stock Options, Non-Vested, Outstanding, Beginning Balance  2,185  
Stock Options, Vested  2,185  
Stock Options, Non-Vested, Outstanding, Ending Balance0 0  
Non-Vested Stock Options, Weighted Average Grant Date Fair Value, Beginning  $ 8.78  
Non-Vested Stock Options, Weighted Average Grant Date Fair Value, Ending$ 0.00 $ 0.00  
Stock Options Vested, Weighted Average Grant Date Fair Value  $ 8.78  
Director [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]     
Restricted Stock in Stock-Based Compensation72,00066,000206,000173,000 
Parent Company [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]     
Total Stock-Based Compensation  7,363,0004,812,000 
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]     
Restricted Stock, Non-Vested, Unrecognized Compensation Cost16,300,000 16,300,000  
Partnership Interest [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]     
Total Stock-Based Compensation  7,363,0004,812,000 
Restricted Stock [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]     
Restricted Stock in Stock-Based Compensation2,696,0001,713,0008,087,0005,138,000 
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]     
Restricted Stock, Non-Vested, Shares Outstanding, Beginning Balance  436,559  
Restricted Stock, Shares Vested and Distributed  171,292  
Restricted Stock, Shares Forfeited  2,745  
Restricted Stock, Non-Vested, Shares Outstanding, Ending Balance574,596 574,596  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]     
Restricted Stock, Non-Vested, Intrinsic Value20,300,000 20,300,000  
Restricted Stock, Shares Vested and Distributed, Weighted Average Grant Price  $ 43.08  
Restricted Stock, Shares Forfeited, Weighted Average Grant Price$ 41.56 $ 41.56  
Restricted Stock, Shares Granted, Total Weighted Average Grant Price$ 41.81 $ 41.81  
Restricted Stock, Vested, Intrinsic Value$ 6,100,000 $ 6,100,000  
Time Based Awards Granted [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]     
Restricted Stock, Shares Granted  128,139  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]     
Restricted Stock, Shares Granted, Weighted Average Grant Price  $ 42.19  
Performance Based Awards Granted [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]     
Restricted Stock, Shares Granted  18,246  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]     
Restricted Stock, Shares Granted, Weighted Average Grant Price  $ 41.54  
Market Based Awards Granted [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]     
Restricted Stock, Shares Granted  165,689  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]     
Restricted Stock, Shares Granted, Weighted Average Grant Price  $ 41.54